期刊文献+

RNAi沉默DLL4基因诱导人乳腺癌细胞凋亡及对多西他赛的增敏作用 被引量:1

Effect of RNAi Silencing of The DLL4 Gene for Inducing Apoptosis and Chemosensitivity to Docetaxel of Human Breast Cancer Cells
原文传递
导出
摘要 目的探讨短发夹RNA(shRNA)靶向沉默DLL4基因对MCF-7细胞凋亡的诱导及对化疗药物多西他赛的增敏作用。方法针对DLL4基因的序列设计具有特异性的shRNA,经脂质体转染MCF-7细胞,作为实验组,空脂质体转染的MCF-7细胞为脂质体组,未做任何处理的MCF-7细胞为对照组。采用免疫细胞化学方法检测3组细胞DLL4蛋白的表达情况;采用流式细胞仪检测3组细胞凋亡率及细胞周期改变;采用噻唑蓝(methyl-thiazoyl-tetrazolium bromide,MTT)法测定3组细胞的增殖情况及对多西他赛的敏感性。结果实验组平均光密度值及阳性面积率均低于对照组和脂质体组(P<0.01);实验组细胞在24 h、48 h及72 h时间点A值均低于对照组和脂质体组(P<0.01);转染后24 h、48 h、72 h及96 h,实验组细胞凋亡率高于对照组和脂质体组(P<0.05);RNA干扰(RNAi)沉默DLL4基因后,实验组G2/M期细胞比例高于对照组和脂质体组(P<0.05);实验组的IC50值较对照组和脂质体组低(P<0.05)。结论 RNAi技术抑制DLL4基因的表达能够抑制MCF-7细胞的增殖、诱导细胞凋亡及增强细胞对多西他赛作用的敏感性。DLL4可能会成为乳腺癌治疗的重要靶点。 Objective To explore effect of DLL4 gene in MCF-7 cells of human breast cancer which was inhibitted by short hair in RNA(shRNA) on inducing apoptosis and chemosensitivity to docetaxel.Methods Specific shRNA was designed in accordance with DLL4 gene and transfected into MCF-7 cells of human breast cancer with liposomal(Lip-shRNA group),MCF-7 cells transfected with only liposomal as Lip group,and control group without any treatment.Expressions of DLL4 protein in 3 groups were detected by immunohistochemical method,apoptosis and cell cycle distribution were examined by flow cytometry(FCM).Proliferations and sensitivity of MCF-7 cells to docetaxel in 3 groups were determined by methylthiazoyl-tetrazolium bromide(MTT).Results The averages optical density value and rate of positive area of Lip-shRNA group were significantly lower than that of other 2 groups(P0.01).The levels of A value at 24 h,48 h,and 72 h in Lip-shRNA group were significantly lower than that of other 2 groups(P0.01).Rates of cell apoptosis at 24 h,48 h,72 h and 96 h in Lip-shRNA group were significantly higher than that of other 2 goups(P0.05), and ratio of G2/M was higher too(P0.05).IC50 of Lip-shRNA group to docetaxel was significantly lower than that of other 2 groups(P0.05).Conclusions The RNA interference technology can effectively block the expression of DLL4 gene.Inhibition of DLL4/Notch signaling pathway can lead to proliferation inhibition of cancer cell and a concomitant increase in cells undergoing apoptosis,and can enhance the cell sensitivity to docetaxel.DLL4 may be an important target for therapeutic approach of breast cancer.
出处 《中国普外基础与临床杂志》 CAS 2013年第1期54-59,共6页 Chinese Journal of Bases and Clinics In General Surgery
关键词 RNA干扰 乳腺癌 Delta样配体4 化疗敏感性 RNA interference Breast cancer Delta-like ligand 4 Chemosensitivity
  • 相关文献

参考文献25

  • 1Patel NS,Li JL,Generali D. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function[J].Cancer Research,2005,(19):8690-8697.doi:10.1158/0008-5472.CAN-05-1208.
  • 2Benedito R,Trindade A,Hirashima M. Loss of notch signalling induced by Dl14 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli[J].BMC Development Biology,2008,(16):117.
  • 3Li JL,Sainson RC,Shi W. Delta-like 4 Notch ligand regulates tumor angiogenesis,improves tumor vascular function,and promotes tumor growth in vivo[J].Cancer Research,2007,(23):11244-11253.
  • 4Shin S,Sung BJ,Cho YS. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7[J].Biochemistry,2001,(04):1117-1123.
  • 5魏爱英,张庆柱,张捷.多西他赛诱导乳腺癌Bcap37细胞凋亡作用的研究[J].中华肿瘤防治杂志,2006,13(18):1384-1386. 被引量:10
  • 6Siekmann AF,Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries[J].Nature,2007,(7129):781-784.doi:10.1038/nature05577.
  • 7Scehnet JS,Jiang W,Kumar SR. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion[J].Blood,2007,(11):4753-4760.
  • 8Hellstr(o)m M,Phng LK,Hofmann JJ. Dl14 signalling through Notchl regulates formation of tip cells during angiogenesis[J].Nature,2007,(7129):776-780.doi:10.1038/nature05571.
  • 9Segarra M,Williams CK,Sierra Mde L. Dl14 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth[J].Blood,2008,(05):1904-1911.
  • 10Dufraine J,Funahashi Y,Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms[J].Oncogene,2008,(38):5132-5137.

二级参考文献79

  • 1刘龙,刘璐,童冠圣,封国生,高宏,高文,李澄,刘志勇.^(32)P-磷酸铬体外诱导人非小细胞肺癌A549细胞凋亡[J].中华放射医学与防护杂志,2004,24(3):233-236. 被引量:2
  • 2任亮,朱宝芹,张轶博,王海燕,李尘远,苏玉虹,巴彩凤.利用软件Primer Premier 5.0进行PCR引物设计的研究[J].锦州医学院学报,2004,25(6):43-46. 被引量:49
  • 3肖毅,冯云路,钱家鸣,陈原稼,林国乐,张月宁,吴斌,邱辉忠.乙酰肝素酶在结直肠癌中的表达及意义[J].中国普外基础与临床杂志,2007,14(4):442-447. 被引量:3
  • 4Ben-Zaken O, Shafat I, Gingis Velitski S, et al. Low and high affinity receptors mediate cellular uptake of heparanase [J]. Int J Biochem Cell Biol, 2008; 40(3) : 530-542.
  • 5Reiland J, Sanderson RD, Waguespack M, et al. Heparanase degrades syndecan-1 and perlecan heparan sulfate functional implications for tumor cell invasion[J]. J Biol Chem, 2004; 279(9) : 8047-8055.
  • 6Xu X, Ding J, Rao G, et al. Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium [J]. Hum Reprod, 2007; 22(4): 927-937.
  • 7Sanderson RD, Yang Y, Suva LJ, et al. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumer growth and metastasis [J]. Matrix Biol, 2004; 23(6) : 341- 352.
  • 8Cohen I, Pappo O, Elkin M, et al. Heparanase promotes growth, angiogenesis and survival of primary breast tumors[J]. Int J Cancer, 2005; 118(7): 1609-1617.
  • 9Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis [J]. Int J Biochem Cell Biol, 2006; 38(12): 2018- 2039.
  • 10Doviner V, Maly B, Kaplan V, et al. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-earcinoma sequence [J]. Mod Pathol, 2006; 19 (6): 878-888.

共引文献18

同被引文献20

  • 1Boisvert WA, Rose DM, Boullier A, et al. Leukocyte transglu- taminase 2 expression limits atherosclerotic lesion size [ J ]. Arte- rioseler Thromb Vasc Biol, 2006, 26(3): 563-569.
  • 2Li Y, Gerbod-Giannone MC, Seitz H, et al. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phago- cytes, which is partially attenuated by the Mer receptor [J]. J Biol Chem, 2006, 281(10): 6707-6717.
  • 3Thorp E, Li G, Seimon TA, et al. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP [J]. Cell Metab, 2009, 9(5): 474-481.
  • 4Tlaorp E, Cui D, Schrijvers DM, et al. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accum- ulation and plaque necrosis in atherosclerotie lesions of apoe-/- mice [J]. Arterioscler Thromb Vase Biol, 2008, 28(8): 1421-1428.
  • 5Ait-Oufella H, Pouresmail V, Simon T, et al. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis [J]. Arterioscler Thromb Vase Biol, 2008, 28(8): 1429-1431.
  • 6Adam LH. Phagocytosis of dying cells: from molecular mechanisms to human diseases [M]. 2th ed, Netherlands: Springer, 2009:189-215.
  • 7Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis [J]. Nat Rev Immunol, 2010, 10(1): 36-46.
  • 8Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis [J]. J Leukoc Biol, 2009, 86(5): 1089-1095.
  • 9T6th B, Garabuczi E, Sarang Z, et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells [J]. J Immunol, 2009, 182(4): 2084-2092.
  • 10Scott RS, Mcmahon EJ, Pop SM, et al. Phagoeytosis and clear- ance of apoptotic cells is mediated by MER [J]. Nature, 2001, 411(6834): 207-211.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部